Evidence Level
Bee pollen research is extensive in vitro and in animal models but limited in human clinical trials. Komosinska-Vassev et al. (2015) published a comprehensive review confirming bee pollen's broad pharmacological activities including antioxidant, anti-inflammatory, hepatoprotective, antimicrobial, and immunomodulatory effects, almost entirely based on preclinical data. Maruyama et al. (2010) provided mechanistic evidence showing bee pollen extract inhibits mast cell degranulation, which underlies its anti-allergy potential. Pascoal et al. (2014) demonstrated immune-enhancing effects in animal models. The allergy desensitization claim — consuming local bee pollen to build tolerance to local allergens — has weak clinical support; a small RCT by Rajan et al. (1986) found no benefit over placebo for hay fever. However, specific flower pollen extracts (Cernilton/Graminex) have shown efficacy for benign prostatic hyperplasia in human trials, though these are pharmaceutical-grade extracts rather than raw bee pollen. The major research limitation is compositional variability — bee pollen from different regions and seasons contains dramatically different bioactive profiles, making it difficult to standardize and compare studies.